Intestinal fibrosis in human and experimental inflammatory bowel disease

Citation
Pk. Lund et Cc. Zuniga, Intestinal fibrosis in human and experimental inflammatory bowel disease, CURR OPIN G, 17(4), 2001, pp. 318-323
Citations number
52
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
CURRENT OPINION IN GASTROENTEROLOGY
ISSN journal
02671379 → ACNP
Volume
17
Issue
4
Year of publication
2001
Pages
318 - 323
Database
ISI
SICI code
0267-1379(200107)17:4<318:IFIHAE>2.0.ZU;2-H
Abstract
Fibrosis is a serious complication of Crohn disease for which there is no e ffective therapy, It is unclear why fibrosis, particularly fibrosis of the mucosal layer, develops in Crohn disease and not in ulcerative colitis. Smo oth muscle cells, subepithelial myofibroblasts, and fibroblasts have tradit ionally been considered mediators of fibrosis, but new information points t o a role of interstitial cells of Cajal and mast cells, Recent evidence abo ut the role of each of these cell types in fibrosis in Crohn disease or oth er inflammatory bowel diseases is described. Hypothetical models to describ e how altered function of these cells could underlie fibrosis of the mucosa or submucosal layers are presented. Fibrosis is not well characterized in any animal model of inflammatory bowel disease, The merits of several anima l models for defining the mechanisms of inflammation-induced intestinal fib rosis are reviewed.